| Serial Number | 90036219 |
| Word Mark | SANSURE |
| Filing Date | Sunday, July 5, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 28, 2023 |
| Registration Number | 6988289 |
| Registration Date | Tuesday, February 28, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 13, 2022 |
| Goods and Services | Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes |
| Pseudo Mark | SAN SURE |
| Goods and Services | Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies |
| Goods and Services | Surgical apparatus and instruments; Blood testing apparatus; Dropping pipettes for medical purposes; Medical devices in the nature of a nucleic acid analyzer for medical diagnosis; Diagnostic apparatus for medical and veterinary purposes, in particular for detecting target nucleic acid molecules in a sample, in particular in a patient sample; Medical apparatus for purifying nucleic acids; Medical nucleic acid amplification and detection apparatus; Medical equipment, namely, devices for bioanalysis of pathogens incorporating cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes, and recorded computer operating software, recorded smartphone operating software provided therein sold as a unit; Medical laboratory instruments for diagnostic use and medical diagnostic instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, fragment analyzers, electrophoresis machines, linkage analyzers, genetic mappers, thermal cyclers, cytometer, chemical reaction mixture containment apparatus and structural parts thereof, protein and peptide synthesizers, mass spectrometer and chromatograph, high-throughput instruments for preparation of nucleic acid samples; Apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; Diagnostic apparatus for medical purposes comprising diagnostic imaging apparatus, displays, monitors and recorded computer operating software, recorded smartphone operating software therefor sold as a unit; Immunochemical testing apparatus for medical use; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other bodily fluids-based, tissue-based, organ-based diagnostic testing, cytology, cell-based, nucleic acid- based, genes-based testing; Analysers for bacterial identification for medical purposes; Apparatus for DNA and RNA testing for medical purposes; Scientific apparatus and instruments, namely, nucleic acid sequencers for use in medical and veterinary diagnosis and in medical and veterinary treatment in the fields of nucleic acid sequencing, genotyping, and genetics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 31, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 1, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 31, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sansure Biotech Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Hunan, 410205 CN |
| Party Name | Sansure Biotech Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Hunan, 410205 CN |
| Party Name | Sansure Biotech Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hunan, 410205 CN |
| Event Date | Event Description |
| Tuesday, February 28, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, February 28, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 7, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 4, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 4, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 4, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 4, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, November 4, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, November 4, 2022 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, October 17, 2022 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
| Monday, October 17, 2022 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Thursday, October 13, 2022 | TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY |
| Wednesday, October 5, 2022 | PETITION INQUIRY LETTER ISSUED |
| Wednesday, October 5, 2022 | REVIEW OF CORRESPONDENCE COMPLETE |
| Monday, October 3, 2022 | ASSIGNED TO PETITION STAFF |
| Tuesday, September 13, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, September 10, 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Saturday, September 10, 2022 | SOU EXTENSION 2 GRANTED |
| Saturday, September 10, 2022 | SOU EXTENSION 2 FILED |
| Saturday, September 10, 2022 | TEAS EXTENSION RECEIVED |
| Wednesday, September 7, 2022 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Friday, April 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 22, 2022 | CORRECTED NOA E-MAILED |
| Thursday, April 21, 2022 | SOU EXTENSION 1 GRANTED |
| Monday, April 4, 2022 | SOU EXTENSION 1 FILED |
| Thursday, April 21, 2022 | DIVISIONAL PROCESSING COMPLETE |
| Monday, April 4, 2022 | DIVISIONAL REQUEST RECEIVED |
| Wednesday, April 20, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, April 4, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, April 4, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, October 19, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 24, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 24, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 4, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 22, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, July 10, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 9, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 11, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, January 11, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, January 11, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, December 28, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, December 1, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, November 4, 2020 | ASSIGNED TO EXAMINER |
| Monday, October 19, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, October 13, 2020 | ASSIGNED TO EXAMINER |
| Friday, July 31, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 8, 2020 | NEW APPLICATION ENTERED |